Related Experiment Video

Updated: Apr 1, 2026

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

4.3K

Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction

Campbell S D Roxburgh1, Donald C McMillan1

  • 1Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom.

Translational Research : the Journal of Laboratory and Clinical Medicine
|October 4, 2015
PubMed

Insights

Cancer treatment is shifting focus from tumor-intrinsic factors to the host

Area of Science:

  • Oncoimmunology
  • Cancer biology
  • Inflammation and cancer

Background:

  • Tumor growth and dissemination were previously thought to be determined by intrinsic tumor characteristics.
  • Emerging research highlights the critical role of local and systemic inflammatory responses in cancer progression and patient survival.
  • Understanding the complex immune/inflammatory responses to cancer is crucial for developing novel therapies.

Purpose of the Study:

  • To explore the potential of targeting host immune/inflammatory responses to improve outcomes in solid tumors.
  • To discuss therapeutic agents, including glucocorticoids and Janus Activated Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) inhibitors.
  • To introduce the concept of oncoimmunology, emphasizing the importance of treating the host alongside the tumor.

Main Methods:

  • Review of recent scientific literature on tumor growth, dissemination, and host inflammatory responses.
  • Analysis of the role of the interleukin-6/Janus Activated Kinase/Signal Transducer and Activator of Transcription (IL-6/JAK/STAT) pathway.
  • Discussion of therapeutic agents targeting immune/inflammatory pathways.

Main Results:

  • Host immune and inflammatory responses significantly influence cancer progression and survival.
  • Targeting innate and humoral immune responses shows promise for improving outcomes in solid tumors.
  • The interleukin-6/Janus Activated Kinase/Signal Transducer and Activator of Transcription (IL-6/JAK/STAT) pathway is a key signal transduction mechanism.

Conclusions:

  • Targeting host immune/inflammatory responses, particularly innate/humoral aspects, offers significant therapeutic potential for solid tumors.
  • Agents like glucocorticoids and Janus Activated Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) inhibitors may improve cancer treatment.
  • Oncoimmunology represents a paradigm shift, necessitating treatment of the host's immune system in cancer therapy.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

950

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K